In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

GHTF's (Global Harmonisation Task Force) new-look website offers updates:

This article was originally published in Clinica

Executive Summary

The Global Harmonisation Task Force (GHTF) has revamped its website, incorporating details of the new Study Group 5 which is focusing on global regulatory convergence in the area of clinical evidence. The new item on SG5 confirms that Dr Graeme Harris, chief clinical adviser at the office of Device, Blood and Tissues at the Therapeutics Goods Administration of Australia, is chair of the study group and that it will meet in Canberra, Australia from January 17-19. Also featured on the updated website are summaries of the following meetings: the SG3 meeting in Erlangen, Germany, on September 14-16; the SG1 meeting in Lisbon on October 5-6; the SG4 meeting on September 27-29 in Canberra, Australia. In addition, there is a calendar of events for 2005 and a participants' list for SG4.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT060243

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel